Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8453609rdf:typepubmed:Citationlld:pubmed
pubmed-article:8453609lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8453609lifeskim:mentionsumls-concept:C0005961lld:lifeskim
pubmed-article:8453609lifeskim:mentionsumls-concept:C0018939lld:lifeskim
pubmed-article:8453609lifeskim:mentionsumls-concept:C0032520lld:lifeskim
pubmed-article:8453609lifeskim:mentionsumls-concept:C1511791lld:lifeskim
pubmed-article:8453609lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:8453609pubmed:issue2lld:pubmed
pubmed-article:8453609pubmed:dateCreated1993-4-20lld:pubmed
pubmed-article:8453609pubmed:abstractTextThirteen male patients affected by different hematologic diseases who underwent bone marrow transplantation (BMT) with female donors were investigated by cytogenetic analysis and polymerase chain reaction (PCR) amplification of a DNA sequence specific for the Y chromosome. In six of these patients, PCR showed the presence of the Y chromosome-related sequence; in only three of these did cytogenetic analysis confirm the presence of mixed chimerism. In the remaining three patients, the results of the PCR were confirmed by in situ hybridization on cell nuclei with a probe for the alpha-satellite of the Y chromosome. We compare results obtained with the two methods and discuss the meaning of the minimal residual disease detected by PCR in patients submitted to BMT.lld:pubmed
pubmed-article:8453609pubmed:languageenglld:pubmed
pubmed-article:8453609pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8453609pubmed:citationSubsetIMlld:pubmed
pubmed-article:8453609pubmed:statusMEDLINElld:pubmed
pubmed-article:8453609pubmed:monthFeblld:pubmed
pubmed-article:8453609pubmed:issn0165-4608lld:pubmed
pubmed-article:8453609pubmed:authorpubmed-author:AntonucciAAlld:pubmed
pubmed-article:8453609pubmed:authorpubmed-author:TorlontanoGGlld:pubmed
pubmed-article:8453609pubmed:authorpubmed-author:CalabreseGGlld:pubmed
pubmed-article:8453609pubmed:authorpubmed-author:PalkaGGlld:pubmed
pubmed-article:8453609pubmed:authorpubmed-author:Di...lld:pubmed
pubmed-article:8453609pubmed:authorpubmed-author:StuppiaLLlld:pubmed
pubmed-article:8453609pubmed:authorpubmed-author:PeilaRRlld:pubmed
pubmed-article:8453609pubmed:authorpubmed-author:Guanciali...lld:pubmed
pubmed-article:8453609pubmed:issnTypePrintlld:pubmed
pubmed-article:8453609pubmed:volume65lld:pubmed
pubmed-article:8453609pubmed:ownerNLMlld:pubmed
pubmed-article:8453609pubmed:authorsCompleteYlld:pubmed
pubmed-article:8453609pubmed:pagination88-92lld:pubmed
pubmed-article:8453609pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:meshHeadingpubmed-meshheading:8453609-...lld:pubmed
pubmed-article:8453609pubmed:year1993lld:pubmed
pubmed-article:8453609pubmed:articleTitleDetection of minimal residual disease by polymerase chain reaction in patients with different hematologic diseases treated by bone marrow transplantation.lld:pubmed
pubmed-article:8453609pubmed:affiliationIstituto di Citomorfologia Umana Normale e Patologica C. N. R. Chieti, Italy.lld:pubmed
pubmed-article:8453609pubmed:publicationTypeJournal Articlelld:pubmed